By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 13 percent jump in revenues for the fourth quarter of 2010 to $483.6 million, compared to $428.8 million a year ago, and exceeding consensus analyst estimates of $464.83.

Driving revenues for the three months ended Dec. 31, 2010, was an increase in uptake of the company's new systems, continued expansion in Asia, and an improved overall economy, Douglas Berthiaume, chairman and CEO of Waters, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.